Atıf Formatları
Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. PAYDAŞ Et Al. , "Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma," ANNALS OF HEMATOLOGY , vol.95, no.1, pp.145-146, 2016

PAYDAŞ, S. Et Al. 2016. Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma. ANNALS OF HEMATOLOGY , vol.95, no.1 , 145-146.

PAYDAŞ, S., OĞUL, A., Irili, C., & GÖKÇAY, S., (2016). Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma. ANNALS OF HEMATOLOGY , vol.95, no.1, 145-146.

PAYDAŞ, SEMRA Et Al. "Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma," ANNALS OF HEMATOLOGY , vol.95, no.1, 145-146, 2016

PAYDAŞ, SEMRA Et Al. "Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma." ANNALS OF HEMATOLOGY , vol.95, no.1, pp.145-146, 2016

PAYDAŞ, S. Et Al. (2016) . "Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma." ANNALS OF HEMATOLOGY , vol.95, no.1, pp.145-146.

@article{article, author={SEMRA PAYDAŞ Et Al. }, title={Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma}, journal={ANNALS OF HEMATOLOGY}, year=2016, pages={145-146} }